Xenograft recipients and the right to withdraw from a clinical trial
Preclinical xenotransplantation research using genetically engineered pigs has begun to show some promising results and could one day offer a scalable means of addressing organ shortage. While it is a fundamental tenet of ethical human subject research that participants have a right to withdraw from...
Authors: | ; ; ; |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Wiley-Blackwell
2024
|
In: |
Bioethics
Year: 2024, Volume: 38, Issue: 4, Pages: 308-315 |
Further subjects: | B
Patient Rights
B xenotransplantation B zoonosis B Public health |
Online Access: |
Presumably Free Access Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |